Evidence map›Paper›PMID 41673005›Full record

ArticleNPJ Parkinson's disease2026

Single-cell analysis of the peripheral immune landscape in Parkinson's disease: insights into dendritic cell and CD4+ T-cell transcriptomics.

Sarah Meglaj Bakrač, Katarina Mandić, Lidija Cvetko Krajinović, Željka Mačak Šafranko, Fran Borovečki, Anja Barešić, Antonela Blažeković

Abstract read
In one paragraph

Article in NPJ Parkinson's disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sarah Meglaj Bakrač *Department for Functional Genomics, Centre for Translational and Clinical Research, University Hospital Centre Zagreb, University of Zagreb School of Medicine, Zagreb, Croatia.
Katarina Mandić *Laboratory for Computational Biology and Translational Medicine, Division of Electronics, Ruđer Bošković Institute, Zagreb, Croatia.
Lidija Cvetko KrajinovićDepartment of Translational Medicine and Immunology, University Hospital for Infectious Diseases 'Dr. Fran Mihaljević', Zagreb, Croatia.
Željka Mačak ŠafrankoDepartment of Translational Medicine and Immunology, University Hospital for Infectious Diseases 'Dr. Fran Mihaljević', Zagreb, Croatia.
Fran BorovečkiDepartment for Functional Genomics, Centre for Translational and Clinical Research, University Hospital Centre Zagreb, University of Zagreb School of Medicine, Zagreb, Croatia.
Anja BarešićLaboratory for Computational Biology and Translational Medicine, Division of Electronics, Ruđer Bošković Institute, Zagreb, Croatia.
Antonela BlažekovićDepartment for Functional Genomics, Centre for Translational and Clinical Research, University Hospital Centre Zagreb, University of Zagreb School of Medicine, Zagreb, Croatia. antonela.blazekovic@mef.hr.

Funding

Croatian Science Foundation DOK-2021-02-5343Croatian Science Foundation IP-2020-02-8475Croatian Science Foundation UIP-2020-02-1623
6 · The paper itself

Abstract

Parkinson's disease (PD) is characterised by α-synuclein aggregation, dopaminergic neuron loss and chronic neuroinflammation. Disruption of the blood-brain barrier enables immune cell infiltration, including dendritic cells (DCs) and CD4+ T-cells, contributing to disease progression. To explore peripheral immune mechanisms in PD, we isolated DCs and CD4+ T-cells from the blood of 17 PD patients and 10 controls using magnetic separation, followed by flow cytometry and single-cell RNA sequencing. Cell-type annotation identified CD4+ T-cell and DC subtypes, including rare DC3 cells. PD patients showed reduced circulating DCs, with no change in CD4+ T-cell levels. Differential gene expression and pathway analysis suggest CD4+ effector memory T-cells (TEMs) and cDC2s as important mediators of immune responses in PD, enriched for immune-related pathways including T-cell activation and antigen presentation. Our findings implicate specific immune subsets in PD-associated neuroinflammation, suggesting cDC2s and CD4

Identifiers

PMID41673005
PMCPMC13004879

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.